Literature DB >> 6462134

Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.

R Machovich, P I Bauer, P Arányi, E Kecskés, K G Büki, I Horváth.   

Abstract

Inactivation of plasmin by a 3-4-fold molar excess of antithrombin III follows pseudo-first-order kinetics and the apparent rate constants are proportional to the concentration of the inhibitor. Heparin accelerates the inactivation reaction without changing its pseudo-first-order character, and the apparent rate constants are also proportional to the concentration of the polysaccharide. Heparin results in a minimum 20-fold rate enhancement of the reaction between plasmin and antithrombin III when the concentrations of heparin and plasmin are approx. 0.5mum and 1mum respectively. Heparin at a molar concentration well below that of plasmin still accelerates the reaction: one molecule of the polysaccharide is able to facilitate the inactivation of about 100 molecules of plasmin. Heparin must bind to plasmin to accelerate the plasmin-antithrombin III reaction, since the modification of four to five lysine residues of the enzyme inhibits the rate-enhancement effect of heparin and the dissociation of heparin-plasmin complex decreases the inactivation rate of plasmin. Increasing the concentration of antithrombin III, at a constant amount of heparin, results in increase of the inactivation rate. By contrast, the effect of increasing the amount of plasmin in the presence of constant amount of heparin and antithrombin III is such that higher plasmin-to-heparin ratios are associated with lower rates of inactivation. It seems, therefore, that to obtain ;optimal' conditions for fast enzyme inactivation, the amount of heparin should be matched to plasmin rather than to antithrombin III. Arrhenius plots of the plasmin-antithrombin III reaction are linear both in the absence and presence of heparin, at concentrations of 1 or 2mug/ml, over a range of 26K. Under these experimental conditions, heparin increases activation entropy. The findings show that heparin seems to fulfil some criteria that are characteristic for biological catalysis: binding, reaction-rate enhancement (increasing activation entropy), recycling of heparin (effectiveness of non-stoichiometric amounts of the polysaccharide) and specificity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6462134      PMCID: PMC1163406          DOI: 10.1042/bj1990521

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  The inactivation of thrombin and plasmin by antithrombin III in the presence of sepharose-heparin.

Authors:  M W Hatton; E Regoeczi
Journal:  Thromb Res       Date:  1977-05       Impact factor: 3.944

2.  Mechanism of action of heparin through thrombin on blood coagulation.

Authors:  R Machovich
Journal:  Biochim Biophys Acta       Date:  1975-11-18

3.  Partial purification and properties of a proteolytic enzyme of human serum.

Authors:  L F REMMERT; P P COHEN
Journal:  J Biol Chem       Date:  1949-11       Impact factor: 5.157

4.  The heparin-thrombin complex in the mechanism of thrombin inactivation by heparin.

Authors:  G F Smith
Journal:  Biochem Biophys Res Commun       Date:  1977-07-11       Impact factor: 3.575

5.  Acrylamide gel electrophoresis of acidic mucopolysaccharides.

Authors:  J C Hilborn; P A Anastassiadis
Journal:  Anal Biochem       Date:  1969-10-01       Impact factor: 3.365

6.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

7.  Multiplicity of rabbit plasminogen. Physical characterization.

Authors:  J M Sodetz; W J Brockway; F J Castellino
Journal:  Biochemistry       Date:  1972-11-21       Impact factor: 3.162

8.  Action of heparin on thrombin-antithrombin reaction.

Authors:  R Machovich; G Blaskó; L A Pálos
Journal:  Biochim Biophys Acta       Date:  1975-01-30

9.  Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.

Authors:  I Danishefsky; M Ahrens; S Klein
Journal:  Biochim Biophys Acta       Date:  1977-06-23

10.  Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.

Authors:  R Einarsson; L O Andersson
Journal:  Biochim Biophys Acta       Date:  1977-01-25
View more
  5 in total

1.  Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies.

Authors:  Brian L Henry; May Abdel Aziz; Qibing Zhou; Umesh R Desai
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

2.  Interaction of plasmin with endothelial cells.

Authors:  P I Bauer; R Machovich; K G Büki; E Csonka; S A Koch; I Horváth
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

3.  Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.

Authors:  L C Petersen; M Jørgensen
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

4.  A catalytic role of heparin within the extracellular matrix.

Authors:  Maria Mitsi; Kimberly Forsten-Williams; Manoj Gopalakrishnan; Matthew A Nugent
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

Review 5.  Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Med Res Rev       Date:  2014-03-21       Impact factor: 12.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.